Dupilumab‐Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib
Pediatric Dermatology · 2026
DOI: 10.1111/pde.70269 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Dermatology, 2026. Verfasst von Grigorios Theodosiou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Antibodies, Monoclonal, Humanized, Psoriasis, Pyrimidines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Psoriasiform eruptions have been described in patients treated with dupilumab. This case report describes an adolescent with severe atopic dermatitis who developed a widespread psoriasiform dermatitis 8 months after starting dupilumab. His therapy was switched to abrocitinib resulting in near‐complete resolution of the psoriatic lesions with good atopic dermatitis control. This case adds to the limited pediatric literature on dupilumab‐induced psoriasis and highlights abrocitinib as an effective therapeutic alternative capable of addressing both conditions concurrently.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, Lund University, Lund, Sweden.
- Department of Dermatology, Skåne University Hospital, Malmö, Sweden.
ORCID-Profile: Grigorios Theodosiou, Åke Svensson
Zitieren
APA
Theodosiou, G., & Svensson, Å. (2026). Dupilumab‐Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib. Pediatric Dermatology. https://doi.org/10.1111/pde.70269
Vancouver
Theodosiou G, Svensson Å. Dupilumab‐Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib. Pediatric Dermatology. 2026. doi:10.1111/pde.70269
BibTeX
@article{Theodosiou2026,
author = {Theodosiou, Grigorios and Svensson, Åke},
title = {Dupilumab‐Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib},
journal = {Pediatric Dermatology},
year = {2026},
doi = {10.1111/pde.70269}
}
EUVIMED